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INSTRUCTION FOR AUTHORS 
SCOPE 
Open Medicine is an international single blind, peer-reviewed, open access journal that publishes original research, 
reviews and news in the field of all Medical Sciences in ongoing way. Our central goal is to provide a hub for 
researchers working across all species to present their discoveries, and to be a forum for the discussion of the 
important issues in the field. The journal accommodates a variety of exposition styles and formats to help scientists 
with diverse backgrounds interact. 
PUBLICATION FORMATS 
Open Medicine considers submissions of:  
 Research Articles, 
 Case reports  
 Communications,  
 Rapid Communications*,  
 Reviews, and Commentaries 
 Letters to the Editor,  
 Erratum,  
 Retraction Note. 
*Rapid Communications are intended to present information of exceptional novelty and exciting results of significant 
interest to the readers. Authors are asked to provide an explanation in the cover letter why their contribution should be 
handled via the rapid channel. 
ELECTRONIC SUBMISSION 
All submissions to Open Medicine must be made via online submission system Editorial Manager at 
http://www.edmgr.com/cejmed/.  
In special situation, if any technical problems occurred, it can be emailed directly to the Managing Editor of the Open 
Medicine (Magdalena Wierzchowiecka, Magdalena.Wierzchowiecka@degruyteropen.com). 
 
Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur in the 
submission and are responsible for its content; they must have agreed to its publication and have given the 
corresponding author the authority to act on their behalf in all matters pertaining to publication. The corresponding 
author is responsible for informing the co-authors of the manuscript status throughout the submission, review, and 
production process. 
Each article accepted for publication in Open Medicine is subject to an Article Processing Charge of €1500. 
 
Electronic Formats Allowed 
We accept submission of text, tables and figures as separate files or as a composite file. For your initial submission, 
we recommend you upload your entire manuscript, including tables and figures, as a single PDF file. If you are invited 
to submit a revised manuscript, please provide us with individual files: an editable text and publication-quality figures. 
Text files can be submitted in the following formats: MS Word - standard DOCUMENT (.DOC) or RICH TEXT 
FORMAT (.RTF); PDF (not applicable for re-submitted or accepted manuscripts, see below). 
Tables should be submitted as MS Word or PDF (not applicable for re-submitted or accepted manuscripts, see 
below). Please note that a straight Excel file is not an acceptable format. 
Graphics files can be submitted in any of the following graphic formats: EPS; BMP; JPG; TIFF; GIF or PDF. Please 
note that Powerpoint files are not accepted. 
Post-acceptance, text files of the revised manuscript and tables are required for use in the production. Authors should 
clearly indicate the location(s) of tables and figures in the text if these elements are given separately or at the end of 
the manuscript. If this information is not provided to the editorial office, we will assume that they should be left at the 
end of the text. 
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First-time Submission of Manuscripts 
It is important that authors include a cover letter with their manuscript. Please explain why you consider your 
manuscript to be suitable for publication in the Journal, why your paper will inspire the other members of your field, 
and how will it drive research forward. 
The letter should contain all important details such as: 
 your full name (submitted by) 
 full title of article and short title 
 full list of authors with affiliations 
 e-mail of the corresponding author 
 contact address, telephone/fax numbers of the corresponding author 
 number of attached files, if there is more than one 
 status: new, reviewed or accepted (with reference ID if reviewed or accepted) 
The cover letter should explicitly state that the manuscript (or one with substantially the same content, by any of the 
authors) has not been previously published in any language anywhere and that it is not under simultaneous 
consideration or in press by another journal. If related work has been submitted, then we may require a preprint to be 
made available. Reviewers will be asked to comment on the overlap between the related submissions. 
Manuscripts that have been previously rejected, or withdrawn after being returned for modification, may be 
resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is a 
resubmission, and the former manuscript number should be provided. 
To ensure fair and objective decision-making, authors must declare any associations that pose a conflict of interest in 
connection with evaluated manuscripts (see Author’s Statements for details). Authors may suggest up to two referees 
not to use, and in such cases additional justification should be provided in the cover letter. Authors are encouraged to 
recommend up to five reviewers who are not members of their institution(s) and have never been associated with 
them or their laboratory(ies); please provide contact information for suggested reviewers. The Editors reserve the right 
to select expert reviewers at their discretion. 
Submission of Revised Articles 
Resubmitted manuscripts should be accompanied by a letter outlining a point-by-point response to Journal Editor's 
and reviewers' comments and detailing the changes made to the manuscript. A copy of the original manuscript should 
be included for comparison if the Journal Editor requests one. If it is the first revision, authors need to return the 
revised manuscript within 28 days; if it is the second revision, authors need to return the revised manuscript within 14 
days. Additional time for resubmission must be requested in advance. If the above mentioned deadlines are not met, 
the manuscript will be treated as a new submission. 
For resubmitted manuscripts, please provide us with an editable text and publication-quality figures: Tables also need 
to be included within an editable article file or be submitted separately as editable files. Supply any figures as separate 
high-resolution, print-ready digital versions. 
In addition to the editorial remarks, authors are asked to take care that they have prepared the revised version 
according to the Journal's style. Please adopt numbered citation (citation-sequence) style referencing. 
PREPARATION OF MANUSCRIPTS  
It is essential that contributors prepare their manuscripts according to the instructions and specifications presented 
below. 
Reporting Guidelines 
De Gruyter Open supports the development of the reporting of biomedical research. Authors of reviews in health 
sciences are recommended to refer to guidelines of the EQUATOR Network and NLM’s Research Reporting 
Guidelines and Initiatives. The similar reporting checklist for biological and biomedical research may be found at 
MIBBI website. Guidelines are available for a number of study designs, including (CONSORT) for randomized 
controlled trials, (PRISMA) for systematic reviews and meta-analyses, (STROBE) for observational studies, (STARD) 
for diagnostic accuracy studies, (RATS) for qualitative studies. 
General Rules for Writing 
The work must demonstrate its novelty, importance to the field and its interest to biomedical community in general. 
Conclusions must be justified by the study; please make your argumentation complete and be self-critical as you 
review your drafts. 
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The Journal encourages the submission of both substantial full-length bodies of work and shorter manuscripts that 
report novel findings that might be based on a more limited range of experiments. There are no specific length 
restrictions for the overall manuscript or individual sections; however, we urge the authors to present and discuss their 
findings in a concise and accessible manner. 
Use simple, declarative sentences and commonly understood terms; avoid long sentences and idle words. Please use 
active voice while writing your manuscript; e.g. ‘we measured snout-vent length’ rather than ‘snout-vent length was 
measured.  We recommend that for clarity you use the past tense to narrate particular events in the past, including the 
procedures, observations, and data of the study that you are reporting. Use the present tense for your own general 
conclusions, the conclusions of previous researchers, and generally accepted facts. Thus, most of the Abstract, 
Methods, and Results should be in the past tense, and most of the Introduction and some of the Discussion should be 
in the present tense. Editors may make suggestions for how to improve clarity and readability, as well as to strengthen 
the argument. 
Organization of the Manuscript 
Articles should be organized into the following sections: 
 Title page with: Title (and running title) 
 Abstract 
 Keywords 
 Introduction 
 Methods 
 Results 
 Discussion 
 Acknowledgments 
 References 
 Figure Legends and Table Captions 
 Tables 
 Figures 
 Supplemental data (if applicable) 
Each of these elements is detailed below. We draw particular attention to the importance of carefully preparing the 
title, keywords and abstract, as these elements are indicators of the manuscript content in bibliographic databases 
and search engines. 
Title 
We suggest the title should be informative, specific to the project, yet concise (75 characters or fewer). Please bear in 
mind that a title that is comprehensible to a broad scientific audience and readers outside your field will attract a wider 
readership. Avoid specialist abbreviations and non-standard acronyms. Titles should not be presented in title case 
(words should not be capitalized). Please also provide a brief "running title" of not more than 50 characters. 
Authors, Affiliations, Addresses 
De Gruyter Open endorses the International Committee of Medical Journal Editors (ICMJE) definition the authorship of 
the work should collectively fulfil the following four criteria: 
1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation 
of data for the work; 
2. Drafting the work or revising it critically for important intellectual content; 
3.  Final approval of the version to be published; 
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or 
integrity of any part of the work are appropriately investigated and resolved. 
Those who do not meet the all four criteria should be acknowledged (see Acknowledgments). It is the sole 
responsibility of contributors to determine the authors of the manuscript submitted to the journal. 
In the cover letter, provide the first names (or initials - if used), middle names (or initials - if used), and surnames for all 
authors. Affiliations should include: 
 Department 
 University or organization 
 City 
 Postal code 
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 State/province (if applicable) 
 Country 
One of the authors should be designated as the corresponding author to whom inquiries regarding the paper should 
be directed. It is the corresponding author's responsibility to ensure that the author list and the summary of the author 
contributions to the study are accurate and complete. Place an asterisk after the name of the corresponding author 
and provide us with a valid e-mail address. Footnotes can be used to present additional information (for example: 
permanent, adequate, present postal addresses). If the article has been submitted on behalf of a consortium, all 
consortium members and affiliations should be listed after the Acknowledgments. 
Addition or Removal of Authors 
The authors’ request for addition or removal of an author should be properly justified. Please note that a change in 
authorship (order of listing, addition or deletion of a name, or corresponding author designation) after submission of 
the manuscript will be implemented only after receipt of signed statements of agreement from all parties involved (all 
listed authors and the author to be removed or added).  
Abstract and Image accompanying abstract 
The abstract should not exceed 200 words. The abstract should give a summary of the content of the paper and is 
usually conceptually divided into: Background, Methodology, Principal Findings/Results, and 
Conclusions/Significance. Mention the techniques used without going into methodological detail and summarize briefly 
the most important items of the paper. Please do not include any citations or references to tables or figures, and avoid 
specialist abbreviations and symbols. Because the abstract will be published separately by abstracting services, it 
must be complete and understandable without reference to the text. 
Authors may provide a striking image to accompany their article, if one is available. If the image (photo, graph, 
scheme) is judged by the editors to be suitable for publication, it may be featured on the web to highlight the paper 
online. It is preferable, but not essential, that these should be related strictly to the subject reported in the manuscript.  
The image could originate from the experimental findings reported in the manuscript but does not have to constitute a 
part of the original work and need not be reprinted in the article. Images must be original and should be submitted as 
separate TIF files format. 
Keywords 
List keywords for the work presented (maximum of 10), separated by commas. We suggest that keywords do not 
replicate those used in the title. Authors should use keywords that are specific and emphasize what is essential in the 
presented study. 
Introduction 
The introduction should put the focus of the manuscript into a broader context and should supply sufficient 
background information to allow the reader to understand and evaluate the results without referring to previous 
publications on the topic. As you compose the introduction, think of readers who are not experts in this field. Include a 
brief review of the key literature - use only those references required to provide the most salient background rather 
than an exhaustive review of the topic. Relevant controversies or disagreements in the field should be mentioned so 
that a non-expert reader can delve into these issues further. The introduction should conclude with a brief statement of 
the rationale for the study, the hypothesis that was addressed or the overall purpose of the experiments reported, and 
should provide a comment about whether that aim was achieved. 
Methods 
This section should include sufficient technical information to enable the experiments to be reproduced. Protocols for 
new methods or significant modifications to existing methods should be included, while previously published or well-
established protocols should only be referenced. Describe new methods completely and give sources of unusual 
chemicals, equipment, strains etc. Studies presented should comply with our recommendations for distribution of 
materials and data (see below). In theoretical papers comprising the computational analyses, technical details 
(methods, models applied or newly developed) should be provided to enable the readers to reproduce the 
calculations. 
The Methods section should contain statements on informed consent, and the authorization for the use of human 
subjects or experimental animals, as appropriate. For details and examples of statements please see “Author’s 
Statements”: 
 
Results 
This section should provide statistical analyses of all of the experiments that are required to support the conclusions of 
the paper. Reserve extensive interpretation of the results for the Discussion section. Details of experiments that are 
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peripheral to the main thrust of the article and that detract from the focus of the article should not be included. Present 
the results as concisely as possible in text, table(s), or figure(s) (see below). Avoid extensive use of graphs to present 
data that might be more concisely presented in the text or tables. Graphs illustrating methods commonly used need 
not be shown except in unusual circumstances. Limit photographs to those that are absolutely necessary to show the 
experimental findings. Number figures and tables in the order in which they are cited in the text, and be sure to cite all 
figures and tables. Styles and fonts should match those in the main body of the article. Large datasets, including raw 
data, should be submitted as supporting files. The section may be divided into subsections, each with a concise 
subheading. 
Discussion 
The Discussion should provide an interpretation of the results in relation to previously published work and to the 
experimental system used. It should not contain extensive repetition of the Results or reiteration of the Introduction. 
This section should spell out the major conclusions of the work along with some explanation or speculation on the 
significance of these conclusions. The discussion should be concise and tightly argued. 
Acknowledgments 
This section should describe sources of funding that have supported the work. Please also describe the role of the 
study sponsor(s), if any, in study design; collection, analysis, and interpretation of data; writing of the paper; and 
decision to submit it for publication. Recognition of personal assistance should be given as a separate paragraph: 
people who contributed to the work, but do not fit the criteria for authors should be listed along with their contributions. 
You must ensure that anyone named in the acknowledgments agrees to being so named. Following the 
Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the 
International Committee of Medical Journal Editors (ICMJE) editors are advised to require that the corresponding 
author obtain written permission to be acknowledged from all acknowledged individuals. 
In this section authors should explicitly reveal all potential financial, personal or professional conflicts of interest. 
Authors should also explicitly state if there is no such conflict regarding the publication of the article. Authors are 
suggested to fill in the ICMJE Conflicts of Interest Form and send the electronic version to the Journal Editor. 
For details and examples of statements please see “Author’s Statements” 
 
References 
Because all references will be linked electronically to the papers they cite, proper formatting of the references is 
crucial. A complete reference should give the reader enough information to find the relevant article. Please pay 
particular attention to spelling, capitalization and punctuation. 
References to unpublished or submitted work, unpublished conference presentations, personal communications, 
patent applications and patents pending, computer software, databases, and websites should be referred to as such 
only in the body of the text. These should be kept to a minimum. The examples are as follows: 
(J. Smith, unpublished data), 
(J. Smith and P. Brown, submitted for publication), 
(J. Smith, personal communication), 
(J. Smith and P. Brown, presented at the 4th Symposium on Food Microbiology, Overton, 
IL, 13 - 15 June 1989), 
(J. C. Odell, April 1970, Process for batch culturing, U.S. patent 484,363,770), 
(J. Smith, 20 June 1999, Australian Patent Office), 
… from the GenBank database (http://www.ncbi.nlm.nih.gov/Genbank/index.html), 
... using ABC software (version 2.2; Department of Microbiology, State University, http://www.stu.micro ), 
Published or accepted ('in press') manuscripts, books and book chapters, and theses should be included in the 
reference list. References to published meeting abstracts should be kept to a minimum. 
For all references, list the first six authors; add "et al." if there are additional authors.  Standard abbreviations of 
journal names according to the style used for MEDLINE should be used. 
Please use the following style for the reference list: 
Published Papers 
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Kulig P., Zabel B.A., Dubin G., Allen S.J., Ohyama T., Potempa J., et al., Staphylococcus aureus-derived staphopain 
B, a potent cysteine protease activator of plasma chemerin, J. Immunol., 2007, 178, 3713-3720 
Accepted Papers 
Kulig P., Zabel B.A., Dubin G., Allen S.J., Ohyama T., Potempa J., et al., Staphylococcus aureus-derived staphopain 
B, a potent cysteine protease activator of plasma chemerin, J. Immunol., (in press), DOI: 12.3412/01 
Electronic Journal Articles 
Dionne M.S., Schneider D.S., Screening the immune system, Genome Biol., 2002,  
http://genomebiology.com/2002/3/4/reviews/1010 
Books and book chapters 
Sambrook J., Russell D.W., Molecular cloning - a laboratory manual, 3rd ed., Cold Spring Harbor Laboratory Press, 
Cold Spring Harbor, 2001 
Theses 
Agutter A.J., Analysis of sigma factors in S. aureus, PhD thesis, Edinburgh University, Edinburgh, UK, 1995 
Conference proceedings 
Smith J., Brown P., Reference style guide, In: M. Scott (Ed.), Proceedings of Biochemical Society Conference (11-13 
July 2007, Warszawa, Poland), Versita Warsaw, 2007, 1335-1791 
Newspaper articles 
Sherwin A., The post-genomic era, The Times, 13 July 2007, 1-2 
M. Dzierzanowski, Horyzonty, Wprost, 8 July 2007, 18 (in Polish) 
References should be listed and numbered in the order that they appear in the text. In the text, citations should be 
indicated by the reference number in brackets [1]. Multiple citations within a single set of brackets should be separated 
by commas [1,2]. Where there are more than three sequential citations, they should be given as a range [1-4]. 
References in figure captions and tables should be listed after references in the text. 
Figures and Figure Legends 
Authors may use photographs, schemes, diagrams, line graphs and bar charts to illustrate their findings. Figures 
included with online submissions should be suitable for onscreen viewing and desktop printing. High resolution images 
should be provided on request or on manuscript acceptance. The figures and their lettering should be clear and easy 
to read, e.g., no labels should be too large or too small. Photomicrographs should include a scaled bar and indicate 
the size. We remind authors that it is not acceptable scientific conduct to modify any separate element within an image 
(adjustments of the entire image in brightness, contrast and color balance are justified only if they do not misrepresent 
the original, observed data). Composite figures composed of grouped images such as insets from different fields or 
separate parts of gels must be explained in the figure legend and differentiated by use of dividing lines or other means 
to make composites unambiguous. Figures should be numbered consecutively using Arabic numerals and referred to 
in the text by number. Figure legends should follow the main text, each on a separate page. Each figure legend should 
have a concise title and should provide enough information so that the figure is understandable without frequent 
reference to the text. It should inform the reader of key aspects of the figure, but the figure should also be discussed in 
the text. The legend should be succinct, while still explaining all symbols and abbreviations. Avoid lengthy descriptions 
of methods. 
Tables and Table Captions 
Tables must include enough information to warrant table format and should be used only where information cannot be 
presented in the text. Tables should be typed as text, using either 'tabs' or a table editor for layout; please do not use 
graphics software to create tables. Tables occupying more than one printed page should be avoided, if possible; 
larger tables can be published as an appendix. Do not use picture elements, text boxes, tabs, or returns in tables. 
Tables that contain artwork, chemical structures, or shading must be submitted as illustrations. Tables should be 
numbered consecutively using Arabic numerals and referred to in the text by number. Table legends should follow the 
main text, each on a separate page. Each table should have an explanatory caption which should be as concise as 
possible. The headings should be sufficiently clear so that the meaning of the data is understandable without 
reference to the text. Footnotes can be used to explain abbreviations but should not include detailed descriptions of 
the experiment. Citations should be indicated using the same style as outlined above. 
Equations 
In-line equations should be typed as text. The use of graphics programs and 'equation editors' should be avoided. 
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Abbreviations 
Please keep abbreviations to a minimum. In addition to abbreviations for Systeme International d'Unités (SI) units of 
measurement, other common units (e.g., bp, kb, and Da), and chemical symbols for the elements, the following should 
be used without definition: DNA; cDNA; RNA; cRNA; RNase; DNase; rRNA; mRNA; tRNA; AMP, ADP, ATP, dAMP, 
ddATP, GTP, etc.; ATPase, dGTPase, etc.; NAD; NAD+; NADH; NADP; NADPH; NADP+; poly(A), poly(dT), etc.; 
oligo(dT), etc.; UV; PFU; CFU; MIC; Tris; DEAE; EDTA; EGTA; HEPES; PCR; and AIDS. Abbreviations for cell lines 
(e.g., HeLa) as well as viruses (e.g., HIV-1, JC virus, BK virus) also need not be defined. Non-standard abbreviations 
should not be used unless they appear at least three times in the text. List all non-standard abbreviations, acronyms 
and symbols in alphabetical order, along with their expanded form, at the end of the text. Define them as well upon 
first use in the text. 
Supplemental Material 
We encourage authors to submit essential supplementary files that additionally support the authors' conclusions along 
with their manuscripts (the principal conclusions should be fully supported without referral to the supplemental 
material). Supplemental material will always remain associated with its article and is not subject to any modifications 
after publication. The decision to publish the material with the article if it is accepted will be made by the Editor. 
Supporting files of no more than 10 MB in may be submitted in a variety of formats, but should be publication-ready, 
as these files will be published exactly as supplied. Material must be restricted to large or complex data sets or results 
that cannot be readily displayed because of space or technical limitations. Material that has been published previously 
is not acceptable for posting as supplemental material. 
Supporting files should fall into one of the following categories: 
 Dataset 
 Additional Figure or Table 
 Text 
 Protocol 
 Multimedia - Audio/Video/Animations (AVI, MPEG, WAV, Quicktime, animated GIF or Flash) 
If the software required for users to view/use the supplemental material is not embedded in the file, you are urged to 
use shareware or generally available/easily accessible programs. To prevent any misunderstandings, we request that 
authors submit a text file (instruction.txt) containing a brief instruction on how to use the files supplied. All supporting 
information should be referred to in the manuscript, with titles (and, if desired, legends) for all files listed under the 
heading 'Supporting Information'. 
Nomenclature 
We strongly recommend the use of correct and established nomenclature wherever possible. Always report numerical 
data (length, weight, and volume) in the appropriate SI units. Please refer to International Union of Pure and Applied 
Chemistry (IUPAC) recommendations available for standard metric units. For these units and for molarity, use the 
prefixes (p= 10-12, n = 10-9, μ= 10-6, m = 10-3, c = 10-2, d = 10-1, h = 102, k = 103, M = 106, G = 109, etc.). Use 
μg/ml or μg/g in place of the ambiguous ppm. When fractions are used to express units, it is preferable to use whole 
units, such as 'g' or 'min', in the denominator instead of fractional or multiple units, such as μg or 10 min (for example 
'pmol/min' is preferable to 'nmol/10 min', and 'μmol/g' is preferable to 'nmol/μg'). It is also preferable that an 
unambiguous form such as exponential notation be used; for example, 'μmol g-1 min-1' is preferable to 'μmol/g/min'. 
Units of temperature are presented in degrees centigrade (i.e. 37°C). 
The recognized authority for the names of chemical compounds is Chemical Abstracts. For guidelines to the use of 
biochemical terminology, consult Biochemical Nomenclature and Related Documents. Do not express molecular 
weight in Daltons: molecular weight is a unitless ratio; molecular mass is expressed in daltons. For enzymes, use the 
recommended name assigned by the Nomenclature Committee of the International Union of Biochemistry. Use the EC 
number when one has been assigned. 
For genes, proteins, strains, clones etc. use the recommended name by consulting the appropriate genetic 
nomenclature database. Genes, mutations, genotypes, and alleles should be indicated in italics; protein products of 
the loci are not italicized. It is sometimes advisable to indicate the synonyms for the gene the first time it appears in 
the text. Gene prefixes such as those used for oncogenes or cellular localization should be shown in roman: v-fes, c-
MYC, etc. 
Formatting and Typesetting 
All pages must be numbered consecutively. The whole text (including legends, footnotes, and references) should be 
formatted double-spaced with no hyphenation and automatic word-wrap (no hard returns within paragraphs). Please 
type your text consistently, e.g. take care to distinguish between '1' (one), 'I' (capital I) and 'l' (lower-case L) and '0' 
(zero) and 'O' (capital O), etc. Manuscript pages should have line numbers. The font size should be no smaller than 12 
points. 
8 
 
Footnotes and endnotes should be avoided. Allowable footnotes/endnotes may include: the designation of the 
corresponding author of the paper, the current address of an author (if different from that shown in the affiliation), 
abbreviations and acronyms. 
Do not create symbols as graphics or use special fonts that are external to your word processing program; use the 
"insert symbol" function. Indicate paragraph lead-ins in bold type and italicize any words that should appear in italics. 
All Latin names should be italicized, including species names and common structures such as: et al.; in vivo; in vitro; 
ex vivo; in silico; etc.; de novo; a priori; ab initio; vice versa; in situ; ad hoc; sensu stricto; i.e.; ca. /circa; n.b. /nota 
bene. Decimal multiples or submultiples of units are indicated by the use of prefixes. There should be a single space 
between most units and the corresponding number; the only exceptions are: 1%, 1‰, 1°C, 1°, 1', 1". 
DISTRIBUTION OF MATERIALS AND DATA 
The publication of an article in the journal is subject to the understanding that authors will make all data and 
associated protocols available to readers on request. The Methods section should include details of how materials and 
information may be obtained. In cases of dispute, authors may be required to make any primary data available to the 
Journal Editor. 
The authors are encouraged to distribute freely any materials used in experiments (cells, strains, clones, antibodies 
etc.) to academic researchers for their own use. Authors are expected to use established public repositories wherever 
possible. All newly reported data including datasets, images, and information (Nucleotide and Amino Acid Sequences, 
Structural Determinations, Microarray Data, Genomic and Proteomic studies, Taxonomy etc.) should be deposited in 
public resources and must be accessible without restriction from the date of publication. Please provide the relevant 
entry name, accession number or identification code in the Methods section. Please note that an author's web site is 
not acceptable for providing this type of information. Authors must deposit their data before submitting their 
manuscripts, or update data already available, so that editors and referees can retrieve the information directly from 
the database. Referees may be asked to comment on the terms of access to materials, methods and/or datasets, and 
Editors reserve the right to refuse publication in cases where authors are unable to provide adequate assurances that 
essential resources will be made freely available to the community. 
Suggested databases include, but are not limited to: 
 ArrayExpress 
 BioModels Database 
 Center for Information Biology Gene Expression Database (CIBEX) 
 Database of Interacting Proteins 
 DNA Data Bank of Japan (DDBJ) 
 EMBL Nucleotide Sequence Database 
 fMRI Data Center 
 GenBank 
 Gene Expression Omnibus (GEO) 
 Nucleic Acid Database 
 Protein Data Bank (http://rcsb-deposit.rutgers.edu and http://pdbdep.protein.osaka-u.ac.jp) 
 UniProtKB/Swiss-Prot 
In addition, as much as possible, please provide accession numbers or identifiers for all entities such as genes, 
proteins, mutants, diseases, etc., for which there is an entry in a public database, for example: 
 Ensembl 
 Entrez Gene 
 FlyBase 
 InterPro 
 Mouse Genome Database (MGD) 
 Online Mendelian Inheritance in Man (OMIM) 
In the case of new software, source code should ideally be made available, for example as supporting information with 
the rest of the paper, or by deposition at a publicly accessible resource such as sourceforge.net. For a new algorithm, 
a detailed description should be published in the paper. In cases where the software/algorithm is not central to the 
paper, we nevertheless encourage authors to make all relevant materials freely available. Software can be provided 
under license where necessary, but any restrictions on the availability or on the use of materials might be judged to 
diminish the significance of a paper, and therefore influence the decision about whether a paper should be published 
subject to those conditions. 
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OUTLINE OF THE PRODUCTION PROCESS 
Once an article has been accepted for publication, the manuscript files are transferred into our production system to 
be language-edited and formatted. Language and technical editors reserve the privilege of editing manuscripts to 
conform with the stylistic conventions of the journal. Once the article has been typeset, PDF proofs are generated so 
that authors can approve all editing and layout. 
Electronic Proofs 
Proofreading should be carried out once a final draft has been produced. Since the proofreading stage is the last 
opportunity to correct the article to be published, the authors are requested to make every effort to check for errors in 
their proofs before the paper is posted online. Please note that only essential changes can be made at this stage and 
extensive corrections, additions, or deletions will not be allowed. Limit changes to correction of spelling errors, 
incorrect data, grammatical errors, and updated information for references to articles that have been submitted or are 
in press. If URLs have been provided in the article, recheck the sites to ensure that the addresses are still accurate 
and the material that you expect the reader to find is indeed there. Important new information that has become 
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